LEADER 04308nam 22007215 450 001 9910300216603321 005 20200701064526.0 010 $a3-319-15807-4 010 $a3-319-15808-2 024 7 $a10.1007/978-3-319-15808-2 035 $a(CKB)2670000000618793 035 $a(EBL)2094453 035 $a(SSID)ssj0001501378 035 $a(PQKBManifestationID)11921004 035 $a(PQKBTitleCode)TC0001501378 035 $a(PQKBWorkID)11524819 035 $a(PQKB)11511090 035 $a(DE-He213)978-3-319-15808-2 035 $a(MiAaPQ)EBC2094453 035 $a(PPN)186025939 035 $a(EXLCZ)992670000000618793 100 $a20150525d2015 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aCardiac Management of Oncology Patients $eClinical Handbook for Cardio-Oncology /$fedited by Gonzalo Baron Esquivias, Riccardo Asteggiano 205 $a1st ed. 2015. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2015. 215 $a1 online resource (264 p.) 300 $aDescription based upon print version of record. 311 08$aPrint version: Cardiac management of oncology patients : clinical handbook for cardio-oncology. Cham, Switzerland : Springer, c2015 ix, 259 pages 9783319158075 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aIntroduction -- Physiopathology and  toxic drugs heart effects -- Radiotherapy heart effects -- Cardiac imaging technology in cardio-oncology -- Evaluation of the oncologic patient before, during and after chemotherapy -- What drug/what possible complication -- What cancer type/what possible drug -- what cancer/what possible complication -- Management (prevention/diagnosis/evaluation/therapy) of hypertension -- Management (prevention/diagnosis/evaluation/therapy) of coronary disease and thrombo-embolic complication -- Management (prevention/diagnosis/evaluation/therapy) of arrhythmic complication -- Management (prevention/diagnosis/evaluation/therapy) of systolic dysfunction. 330 $aIn recent years, progress in oncologic therapy has achieved important goals and a consequent prognostic improvement for patients with malignancy, but cardiac toxicity is often a concern and can have long-term functional or structural effects on the heart. This book is written for the cardiologist working in a clinical environment without support from a specific specialized cardio-oncologist team, and who are called to perform a clinical consultation to evaluate a cardiac condition and the eligibility for a patient to receive chemotherapy or radiotherapy. Cardiac Management of Oncology Patients: Clinical Handbook for Cardio-Oncology is also designed for oncologists and cardiologists to evaluate if a cancer treatment has produced toxic effects on a patient who has either recently or historically been treated with chemo or radiotherapy. The reader will discover more about the cardiac damage potentially created by the oncologic therapy that they are considering for the treatment of their patients. 606 $aCardiology 606 $aOncology   606 $aRadiotherapy 606 $aHematology 606 $aCardiology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33037 606 $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160 606 $aRadiotherapy$3https://scigraph.springernature.com/ontologies/product-market-codes/H29056 606 $aHematology$3https://scigraph.springernature.com/ontologies/product-market-codes/H3307X 615 0$aCardiology. 615 0$aOncology  . 615 0$aRadiotherapy. 615 0$aHematology. 615 14$aCardiology. 615 24$aOncology. 615 24$aRadiotherapy. 615 24$aHematology. 676 $a610 676 $a615842 676 $a616.12 676 $a616.15 676 $a616994 702 $aBaron Esquivias$b Gonzalo$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aAsteggiano$b Riccardo$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910300216603321 996 $aCardiac Management of Oncology Patients$91760498 997 $aUNINA